3 Top Canadian Stocks Now Selling at 52-Week Highs

Stocks like Dye & Durham (TSX:DND) are soaring this week. But are they a buy for momentum investors going long on growth?

| More on:

Momentum investors still have some upside to squeeze from equities before 2020 bites the dust. It’s been a roller coaster of a year, with intense fluctuations in share prices. But some names are going out with a bang. From pot producers to tech IPOs, and with some green energy along the way, some names are hitting year-long highs. Let’s look at three trending Canadian stocks that are still rewarding shareholders as the year comes to a close.

The hot tech stock IPO

Dye & Durham (TSX:DND) is one heck of an intriguing stock. One can see at a glance why its business operations are relevant to the pandemic. Dealing in tech solutions for legal outfits, Dye & Durham also caters to financial services, and government departments. Furthermore, Dye & Durham is looking at annual earnings growth of around 100%.

A 0.17% dividend yield is not much to write home about, but that’s not what this stock is about. Far more important to investors is its sizeable momentum. In the last five days of trading, at the time of writing, Dye & Durham has gained 25%. That’s not bad for a stock that has already appreciated almost 200% within the last five months.

Unfortunately, Dye & Durham is expensive for what it is. Yes, it sells for less than $50 a share. But even with its current price tag of $44, the legal management tech stock is overpriced. Look at its value in terms of real-world assets, for instance. That $44 share price is an off-putting 22 times the company’s book value. This is one to trim for the time being or add to a watch list of stocks to buy on an inevitable pullback.

Cannabis and green power stocks are soaring

Up 115% in 12 months, CuraLeaf Holding’s three-month momentum has been typified by a considerable 63% leap in share price. Selling for less than half its estimated fair value, CuraLeaf could see earnings grow by 73% per year. While it has less than a year of cash runway and has seen some heavy insider selling over the last quarter, CuraLeaf could rake in big revenue growth in 2021. The legal marijuana name just hit a 52-week high, making it a buy for near-term momentum.

The pandemic has boosted the momentum strategy. Recent wins include TransAlta Renewables, beating a year-long record this week. How long such a situation lasts is far from easy to forecast, however. Logically, any future upside is likely to be proportional to its pandemic downside. But a future shift in market share could upend any pre-pandemic growth thesis that these names might have supported in 2019. But while green power looks a perennial buy, some tech stocks could falter.

For instance, Dye & Durham is a niche business that plays to a currently hot tech growth formula. Digitalization is a major trend that existed before the socially distanced tech stock market. But even such a broad economic moat as Dye & Durham’s could prove vulnerable to attack from a reopening rally in 2021 — or, indeed, a series of smaller rallies. Time will tell, but a 2021 recovery could wallop tech IPOs.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Victoria Hetherington has no position in any of the stocks mentioned.

More on Tech Stocks

Man data analyze
Tech Stocks

3 Reasons Celestica Stock Is a Screaming Buy Now

These three reasons make Celestica stock a screaming buy for long-term investors.

Read more »

profit rises over time
Dividend Stocks

These 2 Dow Stocks Are Set to Soar in 2025 and Beyond

Two Dow Jones stocks are screaming buys but Canadians must hold them in an RRSP or RRIF to avoid paying…

Read more »

telehealth stocks
Tech Stocks

Well Health Stock: Buy, Sell, or Hold?

Another record-breaking quarter and strong demand sets the stage for continued momentum for Well Health stock.

Read more »

3 colorful arrows racing straight up on a black background.
Dividend Stocks

TSX Stocks Soaring Higher With No Signs of Slowing

Three TSX stocks continue to beat the market and could soar higher in an improving investment landscape.

Read more »

profit rises over time
Tech Stocks

2 Non-AI Tech Stocks to Buy in November for Better Returns

Not all AI stocks are riding the hype train, and for many investors, well-understood and predictable growth stocks might be…

Read more »

worry concern
Tech Stocks

In a Few Years, You’ll Probably Regret Not Owning BlackBerry Stock

Here’s why I believe BlackBerry could be one of the most overlooked Canadian tech stocks right now.

Read more »

A worker uses a double monitor computer screen in an office.
Tech Stocks

Is Constellation Software Stock a Buy for its 0.25% Dividend Yield?

Here's what investors may want to consider when it comes to Dollarama (TSX:DOL) and its relatively low dividend yield.

Read more »

Nurse talks with a teenager about medication
Tech Stocks

Shares of WELL Health Just Zoomed. Is It a Buy?

Given its improving financials and healthy growth prospects, WELL Health could deliver superior returns over the next three years.

Read more »